Chrysantis, Inc.   Report issue

For profit
Founded: West Chicago IL United States (1998)
Status: Left NME R&D (2017)

Organization Overview

First Clinical Trial
2007
NCT00564902
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

xanthophyll (1 trial)

zeaxanthin (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2